Logotipo del repositorio
  • Español
  • English
  • Iniciar sesión
    Ayuda

    Instrucciones:

    El Repositorio Institucional Académico (RIA) de la Universidad Andrés Bello, es un recurso de acceso abierto. No obstante, y de acuerdo con la ley chilena vigente sobre propiedad intelectual, mantiene en acceso restringido diversos documentos, los cuales sólo pueden ser consultados por la comunidad universitaria registrada. Para poder acceder a éstos, verificar el tipo de usuario y método de acceso, siguiendo las instrucciones que se detallan a continuación:

    • Si eres investigador, docente o funcionario con correo @unab.cl, ingresa utilizando tu usuario de computador o intranet (nombre de usuario sin incluir @unab.cl) y clave.
    • Si eres alumno, profesor adjunto o exalumno con correo @uandresbello.edu, debes registrarte primero, pinchando donde dice Nuevo usuario. Una vez registrado y obtenida el alta, ingresa con el correo electrónico institucional y la clave elegida. El registro se debe realizar utilizando la cuenta de correo institucional, no serán válidas cuentas gmail, hotmail o cualquier otro proveedor.
    • Si eres usuario externo, contactar directamente a repositorio@unab.cl
    o
    ¿Nuevo Usuario? Pulse aquí para registrarse¿Has olvidado tu contraseña?
  • Comunidades
  • Todo RIA
  • Contacto
  • Procedimientos de publicaciónDerecho de autorPolíticas del Repositorio
  1. Inicio
  2. Buscar por autor

Examinando por Autor "Mackern-Oberti, Juan Pablo"

Mostrando 1 - 2 de 2
Resultados por página
Opciones de ordenación
  • Cargando...
    Miniatura
    Ítem
    Modulation of antigen processing by haem-oxygenase 1. Implications on inflammation and tolerance
    (Blackwell Publishing Ltd, 2016-09) Riquelme, Sebastián A.; Carreño, Leandro J.; Espinoza, Janyra A.; Mackern-Oberti, Juan Pablo; Alvarez-Lobos, Manuel M.; Riedel, Claudia A.; Bueno, Susan M.; Kalergis, Alexis M.
    Haem-oxygenase-1 (HO-1) is an enzyme responsible for the degradation of haem that can suppress inflammation, through the production of car bon monoxide (CO). It has been shown in several experimental models that genetic and pharmacological induction of HO-1, as well as non-toxic administration of CO, can reduce inflammatory diseases, such as endo toxic shock, type 1 diabetes and graft rejection. Recently, it was shown that the HO-1/CO system can alter the function of antigen-presenting cells (APCs) and reduce T-cell priming, which can be beneficial during immune-driven inflammatory diseases. The molecular mechanisms by which the HO-1 and CO reduce both APC- and T-cell-driven immunity are just beginning to be elucidated. In this article we discuss recent find ings related to the immune regulatory capacity of HO-1 and CO at the level of recognition of pathogen-associated molecular patterns and T-cell priming by APCs. Finally, we propose a possible regulatory role for HO-1 and CO over the recently described mitochondria-dependent immunity. These concepts could contribute to the design of new therapeutic tools for inflammation-based diseases.
  • Cargando...
    Miniatura
    Ítem
    Surface expression of the hRSV nucleoprotein impairs immunological synapse formation with T cells
    (National Academy of Sciences, 2014-08) Céspedes, Pablo F.; Bueno, Susan M.; Gomez, Roberto S.; Riquelme, Sebastián A.; Palavecino, Christian E.; Mackern-Oberti, Juan Pablo; Mora, Jorge E.; Depoil, David; Sacristań, Catarina; Cammer, Michael; Creneguy, Alison; Nguyen, Tuan H.; Riedel, Claudia A.; Dustin, Michael L.; Kalergis, Alexis M.
    Human respiratory syncytial virus (hRSV) is the leading cause of bronchiolitis and pneumonia in young children worldwide. The recurrent hRSV outbreaks and reinfections are the cause of a significant public health burden and associate with an inefficient antiviral immunity, even after disease resolution. Although several mouse- and human cell-based studies have shown that hRSV infection prevents naïve T-cell activation by antigen-presenting cells, the mechanism underlying such inhibition remains unknown. Here, we show that the hRSV nucleoprotein (N) could be at least partially responsible for inhibiting T-cell activation during infection by this virus. Early after infection, the N protein was expressed on the surface of epithelial and dendritic cells, after interacting with trans-Golgi and lysosomal compartments. Further, experiments on supported lipid bilayers loaded with peptide-MHC (pMHC) complexes showed that surface-anchored N protein prevented immunological synapse assembly by naive CD4+ T cells and, to a lesser extent, by antigen-experienced T-cell blasts. Synapse assembly inhibition was in part due to reduced T-cell receptor (TCR) signaling and pMHC clustering at the T-cell−bilayer interface, suggesting that N protein interferes with pMHC−TCR interactions. Moreover, N protein colocalized with the TCR independently of pMHC, consistent with a possible interaction with TCR complex components. Based on these data, we conclude that hRSV N protein expression at the surface of infected cells inhibits T-cell activation. Our study defines this protein as a major virulence factor that contributes to impairing acquired immunity and enhances susceptibility to reinfection by hRSV.